159 related articles for article (PubMed ID: 24642358)
21. Elevated plasma human urotensin-II-like immunoreactivity in ischemic cardiomyopathy.
Lapp H; Boerrigter G; Costello-Boerrigter LC; Jaekel K; Scheffold T; Krakau I; Schramm M; Guelker H; Stasch JP
Int J Cardiol; 2004 Mar; 94(1):93-7. PubMed ID: 14996481
[TBL] [Abstract][Full Text] [Related]
22. The relationship between coronary slow flow phenomenon and urotensin-II: A prospective and controlled study.
Zengin H; Erbay AR; Okuyucu A; Alaçam H; Yüksel S; Meriç M; Soylu K; Gedikli Ö; Murat N; Gülel O; Demircan S; Akın F; Yılmaz Ö; Şahin M
Anatol J Cardiol; 2015 Jun; 15(6):475-9. PubMed ID: 25430414
[TBL] [Abstract][Full Text] [Related]
23. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
Kowalski M
J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
[TBL] [Abstract][Full Text] [Related]
24. Is elevated urotensin II level a predictor for increased cardiovascular risk in subjects with acromegaly?
Demirpence M; Guler A; Yilmaz H; Sayin A; Pekcevik Y; Turkon H; Colak A; Ari EM; Aslanipour B; Kocabas GU; Calan M
J Endocrinol Invest; 2019 Feb; 42(2):207-215. PubMed ID: 29804270
[TBL] [Abstract][Full Text] [Related]
25. Urotensin-II blockade with SB-611812 attenuates cardiac dysfunction in a rat model of coronary artery ligation.
Bousette N; Hu F; Ohlstein EH; Dhanak D; Douglas SA; Giaid A
J Mol Cell Cardiol; 2006 Aug; 41(2):285-95. PubMed ID: 16797584
[TBL] [Abstract][Full Text] [Related]
26. [Clinical study of changes of urotensin II in patients with congestive heart failure].
Zhong P; Li ZL; Wu HC; Tang CS; Lu Q
Di Yi Jun Yi Da Xue Xue Bao; 2003 Feb; 23(2):121-3. PubMed ID: 12581957
[TBL] [Abstract][Full Text] [Related]
27. Factor XIa and tissue factor activity in patients with coronary artery disease.
Butenas S; Undas A; Gissel MT; Szuldrzynski K; Zmudka K; Mann KG
Thromb Haemost; 2008 Jan; 99(1):142-9. PubMed ID: 18217146
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of antibodies to oxidized low-density lipoprotein and assessment of C-reactive protein in acute coronary syndrome and stable coronary artery disease.
Soltesz P; Veres K; Laczik R; Der H; Csipo I; Timar O; Szomjak E; Szegedi G; Szodoray P
Thromb Haemost; 2007 Aug; 98(2):413-9. PubMed ID: 17721625
[TBL] [Abstract][Full Text] [Related]
29. TH1/TH2 imbalance, measured by circulating and intracytoplasmic inflammatory cytokines--immunological alterations in acute coronary syndrome and stable coronary artery disease.
Szodoray P; Timar O; Veres K; Der H; Szomjak E; Lakos G; Aleksza M; Nakken B; Szegedi G; Soltesz P
Scand J Immunol; 2006 Sep; 64(3):336-44. PubMed ID: 16918703
[TBL] [Abstract][Full Text] [Related]
30. The vasoactive peptides urotensin II and urotensin II-related peptide regulate astrocyte activity through common and distinct mechanisms: involvement in cell proliferation.
Jarry M; Diallo M; Lecointre C; Desrues L; Tokay T; Chatenet D; Leprince J; Rossi O; Vaudry H; Tonon MC; Prézeau L; Castel H; Gandolfo P
Biochem J; 2010 Apr; 428(1):113-24. PubMed ID: 20192922
[TBL] [Abstract][Full Text] [Related]
31. Osteoprotegerin and B-type natriuretic peptide in acute coronary syndromes with preserved systolic function: relation to coronary artery disease extension.
Palazzuoli A; Ascione R; Gallotta M; Calabrò A; Gonnelli S; Quatrini I; Campagna MS; Franci B; Nuti R
Int J Cardiol; 2009 Nov; 137(3):295-8. PubMed ID: 18707771
[TBL] [Abstract][Full Text] [Related]
32. Urotensin II: a novel vasoactive mediator linked to chronic liver disease and portal hypertension.
Kemp W; Krum H; Colman J; Bailey M; Yandle T; Richards M; Roberts S
Liver Int; 2007 Nov; 27(9):1232-9. PubMed ID: 17919235
[TBL] [Abstract][Full Text] [Related]
33. Urotensin II is raised in acute myocardial infarction and low levels predict risk of adverse clinical outcome in humans.
Khan SQ; Bhandari SS; Quinn P; Davies JE; Ng LL
Int J Cardiol; 2007 May; 117(3):323-8. PubMed ID: 16887216
[TBL] [Abstract][Full Text] [Related]
34. Increased gene expression of urotensin II-related peptide in the hearts of rats with congestive heart failure.
Nakayama T; Hirose T; Totsune K; Mori N; Maruyama Y; Maejima T; Minagawa K; Morimoto R; Asayama K; Kikuya M; Ohkubo T; Hashimoto J; Kohzuki M; Takahashi K; Imai Y
Peptides; 2008 May; 29(5):801-8. PubMed ID: 18314225
[TBL] [Abstract][Full Text] [Related]
35. Circulating urotensin II levels in moderate to severe congestive heart failure: its relations with myocardial function and well established neurohormonal markers.
Gruson D; Rousseau MF; Ahn SA; van Linden F; Ketelslegers JM
Peptides; 2006 Jun; 27(6):1527-31. PubMed ID: 16364499
[TBL] [Abstract][Full Text] [Related]
36. Effect of urotensin II on skin microvessel tone in diabetic patients without heart failure or essential hypertension.
Zomer E; de Ridder I; Kompa A; Komesaroff P; Gilbert R; Krum H
Clin Exp Pharmacol Physiol; 2008 Oct; 35(10):1147-50. PubMed ID: 18505448
[TBL] [Abstract][Full Text] [Related]
37. Chemotaxis analysis of circulating monocytes in patients with a recent acute coronary syndrome.
Czepluch FS; Zweigle B; Waltenberger J
Atherosclerosis; 2009 May; 204(1):304-8. PubMed ID: 18842265
[TBL] [Abstract][Full Text] [Related]
38. Copeptin in acute chest pain: identification of acute coronary syndrome and obstructive coronary artery disease on coronary CT angiography.
Dedic A; ten Kate GJ; Rood PP; Galema TW; Ouhlous M; Moelker A; de Feyter PJ; de Rijke YB; Nieman K
Emerg Med J; 2013 Nov; 30(11):910-3. PubMed ID: 23139095
[TBL] [Abstract][Full Text] [Related]
39. Identifying Circulating Urotensin II and Urotensin II-Related Peptide-Generating Enzymes in the Human Plasma Fraction Cohn IV-4.
Schuster R; Steffen P; Dreyer B; Rohn S; Schlüter H; Riedner M
J Proteome Res; 2021 Dec; 20(12):5368-5378. PubMed ID: 34734734
[TBL] [Abstract][Full Text] [Related]
40. Concordant localization of functional urotensin II and urotensin II-related peptide binding sites in the rat brain: Atypical occurrence close to the fourth ventricle.
Bucharles C; Bizet P; Arthaud S; Arabo A; Leprince J; Lefranc B; Cartier D; Anouar Y; Lihrmann I
J Comp Neurol; 2014 Aug; 522(11):2634-49. PubMed ID: 24478001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
